Moses Otunla

Mr. Moses Otunla

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

25 August 2025 in Toxicon
Verified
Journal Article
Closed access
Solomon OwumiSolomon Owumi
Solomon Owumi
JCJoseph Chimezie
Joseph Chimezie
IBIdris O. Bello
Idris O. Bello
MOMoses Otunla
Moses Otunla
UAUche Arunsi
Uche Arunsi
OOOlatunde O. Owoeye
Olatunde O. Owoeye

30 October 2025 in ChemFoodChem
Verified
Journal Article
Open access
Solomon OwumiSolomon Owumi
Solomon Owumi
BOBayode Oluwawibe
Bayode Oluwawibe
HAHarieme Agbarogi
Harieme Agbarogi
MOMoses Otunla
Moses Otunla
Uche Okuu ArunsiUche Okuu Arunsi
Uche Okuu Arunsi
AAAhmad Altayyar
Ahmad Altayyar
Berberine (BER), an alkaloid found in plants like Berberis vulgaris, has beneficial biological effects. Targeting the prepubertal‐to‐adulthood transition, a critical period of growth and metabolic programming, this study investigated whether early‐life BER supplementation confers lasting hepatorenal protection against oxido‐inflammatory stress. Rats received BER (25‐200 mg/kg) from the prepubertal stage (3 weeks old) to adulthood. The study assessed liver and kidney function, oxidative, nitrosative, inflammatory biomarkers, and tissue histopathology. Rats treated with BER (25‐100 mg/kg) showed significant ( p < 0.05 ) dose‐dependent increase in body weight gain compared to the control, suggestive of improved nutrient utilization and growth. BER decreased urea, creatinine, and hepatic transaminase levels and increased antioxidant enzymes, glutathione, and total thiols levels. Also, BER treatment reduced biomarkers of oxido‐inflammatory stress in the liver and kidney, including nitric oxide, TNF‐alpha, xanthine oxidase, myeloperoxidase, malondialdehyde (MDA), reactive oxygen species, and protein carbonyls ( p < 0.05 ). Histological examination revealed healthier liver and kidney tissues in the BER‐treated rats relative to the untreated control. It can be adduced that BER improved cellular redox balance, reduced pro‐inflammatory mediators, and likely promoted the histoarchitectural integrity of the experimental rat liver and kidney with the likely tendency to abate a permissive cellular environment that may result in an adverse pathophysiological state.

18 February 2026 in Toxics
Verified
Journal Article
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP’s controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR “and rodent models’’) AND (“Testosterone Propionate model”) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. We recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.
1

7 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Background: Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP's controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. Method: A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR ‘’ and rodent models’’) AND (“Testosterone Propionate model” ) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Results: Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. Conclusions: we recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.